Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
Summary
- Eligibility
- for people ages 18-80 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Monika Sarkar
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Monika Sarkar
My clinical focus is on women with liver disease, including pregnancy-related liver conditions and reproductive health. My research program is focused on the role of sex hormones in modulating liver disease in women.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- GlaxoSmithKline
- ID
- NCT04950127
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 230 study participants
- Last Updated